Grace Therapeutics, Inc. Public Float
Grace Therapeutics, Inc. (GRCE) had Public Float of $35.05 million as of 2025-09-30, per its 10-K filed 2026-06-18.
Financial Statements › Notes › Cover Page
dei:EntityPublicFloat · last filed 2026-06-18
- 2025-09-30: Entity Public Float $35.05M.
- 2024-09-30: Entity Public Float $24.04M.
- 2023-09-30: Entity Public Float $17.62M.
- 2023-03-31: Entity Public Float $26.03M.
| Period end | Entity Public Float |
|---|---|
| 2025-09-30 | $35.05M 10-K · filed 2026-06-18 |
| 2024-09-30 | $24.04M 10-K · filed 2025-06-23 |
| 2023-09-30 | $17.62M 10-K · filed 2024-06-21 |
| 2023-03-31 | $26.03M 10-K · filed 2023-06-23 |
| 2021-09-30 | $25.94M 10-K/A · filed 2022-07-29 |
| 2020-09-30 | $19.37M 10-K · filed 2021-06-22 |
| 2019-09-30 | $161.01M 10-K · filed 2020-06-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PDS Biotechnology Corp (PDSB) | United States | $0.045B | |
| SCYNEXIS INC (SCYX) | United States | $0.045B | |
| Werewolf Therapeutics, Inc. (HOWL) | United States | $0.047B | |
| VERU INC. (VERU) | United States | $0.043B | -3.93 |
| Dogwood Therapeutics, Inc. (DWTX) | United States | $0.049B | |
| Lite Strategy, Inc. (LITS) | United States | $0.049B | |
| Elicio Therapeutics, Inc. (ELTX) | United States | $0.049B | |
| Kairos Pharma, LTD. (KAPA) | United States | $0.041B | |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |